Cancer Health Treatment Update COVID-19: Changing the Face of Cancer Care The pandemic raises new concerns, but it may also lead to long-lasting improvements. Diverse Gut Microbiome Positively Linked With Immunotherapy Response Metastatic kidney cancer patients with greater microbial diversity had better outcomes with immunotherapy. Sexual Medicine Cancer and its treatment often cause changes in and difficulty with sexual function. A team approach can help prevent or overcome these problems. Predicting Liver Cancer in People Cured of Hepatitis C Readily available clinical parameters can identify those at greatest risk for hepatocellular carcinoma. Who Is Most Susceptible to COVID-19? Age, underlying medical conditions, race/ethnicity and economic status all play a role in determining the risk for severe illness. Click here for all Cancer Health coverage of COVID-19, including how it affects people living with cancer. For other news about the coronavirus, visit our new sister site, COVID Health. News From the AACR Annual Meeting & COVID-19 and Cancer Meeting See all our reports from these recent virtual cancer research conferences. Cancer Health Fall 2020 Check out our latest print edition! Advertisement Newsfeed How COVID-19 Set the World Back 25 Years in 25 Weeks Why the Coronavirus Is Less Likely to Spread at the Gym Than in a Bar NIH ‘Very Concerned’ About Serious Side Effect in Coronavirus Vaccine Trial Braving the Cold of Antarctica to Raise Money for Cancer Blog: Food and Drug Administration (FDA) FDA Issues Alert About Tecentriq Plus Paclitaxel for Breast Cancer FDA Approves Onureg for Acute Myeloid Leukemia FDA Updates Analysis of Medical Device Reports of Breast Implant Illness and Breast Implant-Associated Lymphoma FDA approves Kyprolis Plus Darzalex Combination for Multiple Myeloma Newsfeed How COVID-19 Set the World Back 25 Years in 25 Weeks Why the Coronavirus Is Less Likely to Spread at the Gym Than in a Bar NIH ‘Very Concerned’ About Serious Side Effect in Coronavirus Vaccine Trial Braving the Cold of Antarctica to Raise Money for Cancer Blog: Food and Drug Administration (FDA) FDA Issues Alert About Tecentriq Plus Paclitaxel for Breast Cancer FDA Approves Onureg for Acute Myeloid Leukemia FDA Updates Analysis of Medical Device Reports of Breast Implant Illness and Breast Implant-Associated Lymphoma FDA approves Kyprolis Plus Darzalex Combination for Multiple Myeloma

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@cancerhealth.com. Please remember to add update@cancerhealth.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is: